• 검색 결과가 없습니다.

Clinical Outcome for High-dose Pralidoxime in Treating Organophosphate Intoxication

N/A
N/A
Protected

Academic year: 2021

Share "Clinical Outcome for High-dose Pralidoxime in Treating Organophosphate Intoxication"

Copied!
5
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1. Characteristics of low dose pralidoxime use (12 g) and high dose paralidoxime use (24 g) in organophosphate poisoned patients
Table 2. Clinical outcomes of low dose pralidoxime use (12 g/day) and high dose paralidoxime use (24 g/day) in organophosphate poi- poi-soned patients
Fig. 1. Comparison of group 1 with group 2 for the change of mean cholinesterase level.

참조

관련 문서

지구의의 위치에 따라 태양의 남중 고도가 달라지는 경우를 골라 기호를 썼지만 이를 통해 알 수 있는 계 절이 변하는 까닭을 쓰지 못했다.. 하 알맞은 그래프의 형태를

In this group of high-risk patients with severe COVID-19 pneumonia, treatment with lenzilumab was associated with a significantly shorter time to clinical improvement compared

동결방지 조치를 취하여 등을 사용하여 적절한 우려가 있는 곳은 보온재 드레인 호스 설치시 동결.

Early efficacy signals in the mid dose cohort suggest positive biological activity and potential early clinical benefits. High dose adult cohort is currently ongoing with no

[r]

3 Mean percentages of bone implant contact ratio in the control group and experimental groups at 6 and 12 weeks after placement of the

In the analysis of soluble solids, the treatment group with material grains and the combined groups of glutinous millet and barley appeared high, and

Second, overall satisfaction with facilities and environments, manpower, working conditions and treatment, and programs for protected workplaces was high,